DEUTSCHE BANK AG\ - VTV THERAPEUTICS INC ownership

VTV THERAPEUTICS INC's ticker is VTVT and the CUSIP is 918385105. A total of 22 filers reported holding VTV THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of VTV THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$18,000
+38.5%
6,360
-9.6%
0.00%
Q4 2020$13,000
+44.4%
7,032
+42.8%
0.00%
Q3 2020$9,000
-10.0%
4,926
+10.3%
0.00%
Q2 2020$10,000
-37.5%
4,468
-45.9%
0.00%
Q1 2020$16,000
+6.7%
8,261
-10.8%
0.00%
Q4 2019$15,000
+66.7%
9,261
+46.6%
0.00%
Q2 2019$9,0006,316
+1124.0%
0.00%
Q1 2019$0
-100.0%
516
-99.8%
0.00%
Q2 2018$323,000
+166.9%
210,720
+603.5%
0.00%
Q1 2018$121,000
+22.2%
29,953
+81.1%
0.00%
Q4 2017$99,000
+32.0%
16,536
+29.3%
0.00%
Q3 2017$75,000
-59.9%
12,790
-66.2%
0.00%
Q2 2017$187,000
+8.1%
37,864
+43.0%
0.00%
Q1 2017$173,000
+26.3%
26,486
-7.7%
0.00%
Q4 2016$137,000
-4.2%
28,699
+44.0%
0.00%
Q3 2016$143,000
+1942.9%
19,925
+1357.6%
0.00%
Q2 2016$7,000
+40.0%
1,367
+23.6%
0.00%
Q1 2016$5,000
-50.0%
1,106
-35.5%
0.00%
Q4 2015$10,000
-33.3%
1,716
-29.1%
0.00%
Q3 2015$15,0002,4190.00%
Other shareholders
VTV THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 300,000$1,491,0000.25%
SABBY MANAGEMENT, LLC 117,400$583,0000.04%
ESSEX INVESTMENT MANAGEMENT CO LLC 39,779$198,0000.03%
Candriam S.C.A. 140,000$696,0000.01%
Alyeska Investment Group, L.P. 204,523$1,016,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 11,396$57,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$373,0000.00%
FRANKLIN RESOURCES INC 899,100$4,469,0000.00%
AMERIPRISE FINANCIAL INC 264,214$1,313,0000.00%
SG Americas Securities, LLC 12,845$64,0000.00%
View complete list of VTV THERAPEUTICS INC shareholders